Sort by
Refine Your Search
-
cutting-edge in situ technologies (cryoFIB/SEM and cryoET) to explore the chromatin architecture at the integration targeting sites. It is essential that you hold a PhD/DPhil (or close in completion) in
-
. The postholder will work in the group of Simon Myers (University of Oxford), which works broadly on statistical genetics, and genomics, including of variants impacting human phenotypes and their evolution. This is
-
-scale data. The postholder will work in the group of Simon Myers (University of Oxford), which works broadly on statistical genetics, and genomics, including of variants impacting human phenotypes and
-
to Dr Jani R Bolla. The work is to be conducted in his lab in the Department Biology, University of Oxford, South Parks Road, Oxford, OX1 3RB. The postholder will support ongoing research that aims
-
the discipline of work including as a first author is essential, as well as experience of original deep learning in imaging architecture design and evaluation. Informal enquiries may be addressed to Professor
-
brings together world-leading centres at the Universities of Oxford, Edinburgh, Strathclyde and Sheffield. CoTide’s team of around 35 researchers and academics will develop holistic integrated models
-
. The CoTide project team brings together world-leading centres at the Universities of Oxford, Edinburgh, Strathclyde and Sheffield. CoTide’s team of around 35 researchers and academics will develop holistic
-
, University of Oxford, Imperial College, University of British Columbia, University of Sydney, University of Newcastle and Aalto University. There are also ample opportunities for collaborations with other
-
is built in association with the following international partners: • University of Oxford • Massachusetts Institute of Technology (MIT) • University of British Columbia (UBC) • Stanford University
-
an EPSRC Prosperity Partnership between Universities of Oxford (Williams) and Unilever focussed on producing sustainable materials for consumer products and liquid formulations. Our research targets new